© 2009 by BMJ Publishing Group & British Cardiac Society
Viewpoint
"Prevention of cardiovascular disease: why do we neglect the most potent intervention?
1 University College London, United Kingdom;
2 General Practitioner, United Kingdom
Correspondence to: Emmanuel Stamatakis, Epidemiology and Public Health, University College London, 1-19 Torrington Place, London, WC1E 6BT, United Kingdom; e.stamatakis{at}ucl.ac.uk
Accepted 20 October 2009
Despite a large volume of evidence supporting its cardio-protective properties and its numerous other established health benefits, physical activity is not a serious prescription option for the primary prevention of cardiovascular disease. On the other hand, health services increasingly focus on pharmacological prevention without considering properly the long-term consequences of medication. Ethical and feasibility considerations suggest that evidence on the protective value of physical activity may needs to be evaluated using criteria different to those applying to pharmacological trials. The collateral health benefits of physical activity prescription support its use as standard option in preventive health.
Register for free content
The full back archive is now available for all BMJ Journals. Institutional subscribers may access the entire archive as part of their subscription. Personal subscribers will also have access to all content when logged in. Non-subscribers who register have free access to all articles published before 2006 right back to volume 1 issue 1. Register here to access the free archive of all BMJ Journals.
Don't forget to sign up for content alerts so you keep up to date with all the articles as they are published.
